Pfizer and Allergan announced their merger.

The resulting company will be the world’s largest pharmaceutical manufacturer. Transaction is estimated at 160 bln USD. Pfizer’s desire to decrease the tax from 35% in the U.S. to 12.5% in Ireland is the main reason for the merger. According to earlier analytical reports, US Treasury Department planned to apply more stringent…

Read more

Teva is leading the global market of generics.

Company had a 12.2% share of the 74.2 bln USD market in 2014, according to EvaluatePharma®. Sandoz was in the second place with an 11.5% market share. Mylan, Actavis and Sun Pharmaceutical Industries with a total share of 5% also made the TOP-20 list. 83.1% of the market belonged to TOP-20 companies. The market continues to evolve…

Read more

The global market of plant-derived pharmaceuticals will add 34% in the next five years and total US $34.5 bln in 2020, according to BBC Research.

Only drugs of 100% plant origin fall into this category. Plant-based drugs include dried plants, tinctures, liquid and dry extracts. Extracts, which contain only a part of the original plant matter, can be composed of one or several active ingredients. Russian market of plant-based drugs averages 100 mln packs and 5-6 bln rubles…

Read more

The share of domestic manufacturers in High Cost Nozologies (VZN) segment grew from 11% to 38% in the first six months of 2015 versus the same period a year earlier.

The launch of Russian-made biosimilar versions of drugs for Myeloid Leukemia made this possible. Russian products replaced former leaders of the segment Mabthera (rituximab), Roche, Velcade (bortezomib), J&J and Glivec (imatinib), Novartis. Top 10 products in the program are shown in the table below.

Read more

US FDA accepted an NDA for the first-ever digital pill

Otsuka Pharmaceuticals and Proteus Digital Health filed the joined application. The new product is a variation of Abilify (Otsuka/BMS) additionally equipped with a digital sensor. Connection with another sensor embedded into a wearable adhesive patch allows to monitor compliance and patients physiological responses, such as rest,…

Read more

Russian President Vladimir Putin signed a list of instructions on health care issues.

Russian government will centralize state procurement of drugs for TB, HIV infection and viral Hepatitis before February 16, 2016. It will also select a single supplier of state procured blood plasma products. The Ministry of Health and the Ministry of Industry and Trade jointly with Rostec state…

Read more

Physicians in hospitals can prescribe drugs by trade name again.

The Ministry of Health previously outlawed this practice in its Order #1174, which went into effect on July 1, 2013. Prescriptions by trade name were only possible if a medical board identified intolerance of certain drugs. The order meant to solve the corruption and illegal arrangements between physicians and pharmaceutical companies.…

Read more

EvaluatePharma released the 2015 Pharma and Biotech Half-Year Review.

Report’s key findings:

  • Industry’s leading stock indices (NASDAQ Biotechnology, S&P Pharmaceuticals, Dow Jones Pharma and Biotech) continued to grow. Nasdaq Biotechnology exceeded the market average by adding 22% in the first six months. The index grew 270% since 2012.
  • First half-year top winners in the…
Read more